Cortica, a company specializing in care for autistic and neurodivergent children, has raised $80 million in funding from Morgan Health and Nexus NeuroTech Ventures.
The investment will be used to expand the company's value-based care contracts and improve its operational footprint.
Cortica aims to provide faster evaluation, diagnosis, and treatment processes for patients with autism.
The company offers comprehensive care through an interdisciplinary approach and a range of services.
The funding will help Cortica address the growing demand for autism services and provide integrated solutions in the healthcare landscape.
The company's model aims to reduce reliance on medications and achieve cost savings for families and payers.
Morgan Health's investment in Cortica is part of its strategic approach to foster innovation in the employer-sponsored healthcare market.
Cortica's willingness to engage in risk-sharing contracts is a significant factor in its appeal to Morgan Health.
The company plans to serve over 24,000 patients and their families in 2024.
By addressing the challenges faced by families and enhancing the quality of care, Cortica aims to redefine the standards of autism treatment and support.